Insider Trading & Ownership - Mulroy Michael H.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Mulroy Michael H.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-03-24
Purchase
2022-03-25
4:15 pm
Lineage Cell Therapeutics Inc.LCTXMulroy Michael H.
Director
7,000$1.4$9,800258,555
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-07-01
Option Award
2023-07-03
5:46 pm
N/A
2033-07-01
Lineage Cell Therapeutics Inc.LCTXMulroy Michael H.
Director
50,000$050,000
(Direct)
View
2022-07-01
Option Award
2022-07-06
4:15 pm
N/A
2032-07-01
Lineage Cell Therapeutics Inc.LCTXMulroy Michael H.
Director
50,000$050,000
(Direct)
View
2021-07-01
Option Award
2021-07-01
6:19 pm
N/A
2031-07-01
Lineage Cell Therapeutics Inc.LCTXMulroy Michael H.
Director
50,000$050,000
(Direct)
View
2021-06-18
Exercise
2021-06-21
4:15 pm
N/A
2021-06-30
Lineage Cell Therapeutics Inc.LCTXMulroy Michael H.
Director
24,720$0251,555
(Direct)
View
2021-06-18
Exercise
2021-06-21
4:15 pm
N/A
N/A
Lineage Cell Therapeutics Inc.LCTXMulroy Michael H.
Director
24,720$2.2251,555
(Direct)
View
2020-07-01
Option Award
2020-07-02
5:04 pm
N/A
2030-07-01
Lineage Cell Therapeutics Inc.LCTXMulroy Michael H.
Director
40,000$040,000
(Direct)
View
2019-07-01
Option Award
2019-07-03
9:12 pm
N/A
2029-06-30
BIOTIME INCBTXMulroy Michael H.
Director
40,000$040,000
(Direct)
View